Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Günzel

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|December 1, 1973
[Prolactin cell tumors in animal experiments and in man]M F el-Etreby, P Günzel
Steroids|September 1, 1977
Isolation and identification of 15-beta-hydroxy cyproterone acetate as a new metabolite of cyproterone acetate in dog, monkey and manA S Bhargava, A Seeger, P Günzel
Toxicology Letters|January 1, 1990
The use of urinary N-acetyl-beta-D-glucosaminidase (NAG) for the detection of contrast-media-induced 'osmotic nephrosis' in ratsR Hofmeister, A S Bhargava, P Günzel
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombinA S Bhargava, J Heinick, P Günzel
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1986
Value of enzyme determinations in urine for the diagnosis of nephrotoxicity in ratsR Hofmeister, A S Bhargava, P Günzel
Zeitschrift Fur Versuchstierkunde|January 1, 1973
[Determination of primary bleeding time in the dog]H H Sedlacek, P Günzel, K Dannehl
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparinA S Bhargava, G Freihube, P Günzel
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human bloodA S Bhargava, G Freihube, P Günzel
Arzneimittel-Forschung|January 1, 1981
Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. applicationA S Bhargava, H Wendt, P Günzel
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1993
Serum lipoprotein pattern in rats, dogs and monkeys, including method comparison and influence of menstrual cycle in monkeysR Lehmann, A S Bhargava, P Günzel
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|December 1, 1973
[Prolactin cell tumors in animal experiments and in man]M F el-Etreby, P Günzel
Steroids|September 1, 1977
Isolation and identification of 15-beta-hydroxy cyproterone acetate as a new metabolite of cyproterone acetate in dog, monkey and manA S Bhargava, A Seeger, P Günzel
Toxicology Letters|January 1, 1990
The use of urinary N-acetyl-beta-D-glucosaminidase (NAG) for the detection of contrast-media-induced 'osmotic nephrosis' in ratsR Hofmeister, A S Bhargava, P Günzel
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombinA S Bhargava, J Heinick, P Günzel
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1986
Value of enzyme determinations in urine for the diagnosis of nephrotoxicity in ratsR Hofmeister, A S Bhargava, P Günzel
Zeitschrift Fur Versuchstierkunde|January 1, 1973
[Determination of primary bleeding time in the dog]H H Sedlacek, P Günzel, K Dannehl
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparinA S Bhargava, G Freihube, P Günzel
Arzneimittel-Forschung|January 1, 1980
Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human bloodA S Bhargava, G Freihube, P Günzel
Arzneimittel-Forschung|January 1, 1981
Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. applicationA S Bhargava, H Wendt, P Günzel
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1993
Serum lipoprotein pattern in rats, dogs and monkeys, including method comparison and influence of menstrual cycle in monkeysR Lehmann, A S Bhargava, P Günzel
Pageof 5